Shares of Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the ten ratings firms that are covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $54.22.
Several equities analysts have recently issued reports on the company. Bank of America lowered Tempus AI from a "buy" rating to a "neutral" rating and lifted their price target for the company from $45.00 to $60.00 in a research note on Wednesday, October 2nd. Piper Sandler reiterated a "neutral" rating and issued a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Stifel Nicolaus lowered Tempus AI from a "buy" rating to a "hold" rating and boosted their price objective for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Finally, Loop Capital upped their target price on Tempus AI from $48.00 to $57.00 and gave the stock a "buy" rating in a report on Tuesday, October 15th.
Get Our Latest Stock Analysis on Tempus AI
Tempus AI Stock Performance
Shares of TEM traded down $2.72 during mid-day trading on Friday, reaching $50.44. The company's stock had a trading volume of 2,802,905 shares, compared to its average volume of 1,217,800. Tempus AI has a 1-year low of $22.89 and a 1-year high of $79.49. The business's 50-day moving average price is $53.61. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently made changes to their positions in the company. First Horizon Advisors Inc. bought a new stake in shares of Tempus AI in the 3rd quarter worth approximately $30,000. Sandia Investment Management LP bought a new position in shares of Tempus AI during the 2nd quarter valued at $136,000. Vestor Capital LLC bought a new position in shares of Tempus AI during the 3rd quarter valued at $153,000. Stifel Financial Corp bought a new position in shares of Tempus AI during the 3rd quarter valued at $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new position in shares of Tempus AI during the 3rd quarter valued at $258,000.
About Tempus AI
(
Get Free ReportTempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Further Reading
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
